Skip to content

What Pain Patches Do Hospitals Use? A Guide to Clinical Transdermal Pain Relief

5 min read

In hospital settings, transdermal analgesic patches offer a method of delivering pain medication with a consistent, controlled release, avoiding the peaks and troughs of oral medication. This approach is particularly beneficial for patients with stable pain conditions, offering reliable relief for days at a time.

Quick Summary

This article explores the types of transdermal pain patches used in hospitals, including potent opioids, local anesthetics, and NSAIDs. It details their specific applications, benefits, and safety protocols for clinical use.

Key Points

  • Diverse patch options: Hospitals use various pain patches, including opioid patches like Fentanyl and Buprenorphine for severe pain and anesthetic patches like Lidocaine for localized nerve pain.

  • Fentanyl for chronic pain: Strong opioid Fentanyl patches provide continuous, long-acting relief for patients with severe chronic or cancer pain, typically changed every 72 hours.

  • Lidocaine for nerve pain: Lidocaine 5% patches (Lidoderm) are used to numb localized nerve pain, such as from shingles, and are applied to intact skin for up to 12 hours.

  • Transdermal advantages: The patch delivery method offers stable drug concentrations, improved compliance for certain patients, and fewer systemic side effects compared to oral routes.

  • Heat exposure risks: External heat sources like heating pads can increase the absorption rate of opioid patches and cause a dangerous overdose, requiring strict patient warnings.

  • Careful disposal is required: Used opioid patches contain residual medication and must be folded and disposed of according to hospital protocol, often by flushing, to prevent accidental exposure.

  • Not for all pain types: Extended-release transdermal patches are typically for stable chronic pain and not suitable for sudden or mild pain, which require immediate-release medication.

In This Article

Pain management is a critical component of hospital care, and transdermal patches have become an important tool for delivering controlled, long-term pain relief. By delivering medication directly through the skin, these patches bypass the digestive system, ensuring a consistent drug level in the bloodstream and reducing common gastrointestinal side effects. Different patches contain different medications and are used for specific pain conditions and durations. Here is an overview of the pain patches used in clinical settings.

Strong Opioid Patches: Fentanyl and Buprenorphine

For severe, persistent pain that requires around-the-clock opioid treatment, hospitals often use transdermal patches containing potent opioid analgesics.

Fentanyl Patches (e.g., Duragesic)

Fentanyl is a powerful synthetic opioid used for managing moderate to severe chronic pain, especially in opioid-tolerant patients.

  • How it works: Fentanyl is slowly absorbed through the skin, creating a depot in the underlying subcutaneous tissue. From there, it enters the bloodstream, providing steady pain relief for up to 72 hours (3 days).
  • Hospital use: Commonly used for chronic pain, such as that associated with cancer, and sometimes in post-operative settings. Patches are replaced every 72 hours, with the dose adjusted as needed.
  • Patient-controlled option: A specific fentanyl patch system, Ionsys, is designed for in-hospital use, allowing patients to administer small, controlled doses for short-term acute post-operative pain.

Buprenorphine Patches (e.g., Butrans)

Buprenorphine is a partial opioid agonist used for long-term management of moderate to severe chronic pain.

  • How it works: Similar to fentanyl, buprenorphine is delivered transdermally to provide a continuous, stable level of pain relief. Depending on the brand, patches are typically changed every three or seven days.
  • Hospital use: The buprenorphine patch is indicated for chronic pain, and studies have shown its effectiveness in controlling post-operative pain following certain procedures. Its ceiling effect on respiratory depression at higher doses makes it a potentially safer alternative for some patients.

Local Anesthetic Patches: Lidocaine

For localized nerve-related pain, hospitals often turn to lidocaine patches, which act directly on the nerves to numb the painful area.

Lidocaine Patches (e.g., Lidoderm 5%)

  • How it works: The patch delivers lidocaine, a local anesthetic, to the skin, where it blocks pain signals from the underlying nerves. The concentration in the bloodstream remains very low, minimizing systemic side effects.
  • Hospital use: Primarily used for post-herpetic neuralgia (PHN), the nerve pain that can follow a shingles infection. The patch is typically worn for 12 hours within a 24-hour period.

Other Topical Analgesic Patches

In some cases, other topical patches might be used for localized relief of minor pain, such as those containing nonsteroidal anti-inflammatory drugs (NSAIDs) like diclofenac, or capsaicin for neuropathic pain. These patches work by concentrating the medication in the affected area with minimal systemic absorption.

Comparison of Pain Patches Used in Hospitals

Feature Fentanyl (Opioid) Buprenorphine (Opioid) Lidocaine (Local Anesthetic)
Drug Type Potent Opioid Agonist Partial Opioid Agonist Local Anesthetic
Indication Severe, chronic pain; post-op pain (Ionsys) Moderate-to-severe chronic pain Localized neuropathic pain (e.g., PHN)
Delivery Transdermal (systemic) Transdermal (systemic) Topical (local)
Duration 72 hours 3 to 7 days 12 hours on, 12 hours off
Key Benefit Long-acting, consistent, and potent relief Long duration, lower risk of severe respiratory depression Numbing effect with minimal systemic side effects
Considerations Not for mild/acute pain; potential for overdose with heat exposure Not for mild/acute pain; possible application site irritation Requires intact skin; no high systemic concentration achieved

Benefits of Pain Patches in a Hospital Setting

  • Consistent Dosing: Patches provide a steady drug level, which can offer more stable pain relief compared to intermittent oral or injection dosing.
  • Improved Compliance: For patients who have trouble swallowing or experience nausea, a patch offers a simpler, non-invasive method of medication delivery.
  • Reduced First-Pass Metabolism: Transdermal patches bypass the liver's first-pass metabolism, which improves bioavailability and allows for lower overall drug dosage.
  • Fewer Side Effects: Localized patches, such as lidocaine, minimize systemic absorption, reducing the risk of widespread side effects. Opioid patches can also cause fewer side effects like constipation compared to oral opioids.

Safety Protocols for Pain Patches in Hospitals

Due to the potency of these medications, especially opioids, hospital protocols emphasize safety in administration and disposal. Healthcare providers are trained to follow strict guidelines to prevent accidental exposure and misuse.

Best practices include:

  • Careful Application: The patch should be applied to clean, dry, hairless, and intact skin. The site should be rotated with each new patch to prevent irritation.
  • Monitoring: For opioid patches, patients are monitored, particularly in the initial 24-72 hours, for signs of respiratory depression. Patient education on recognizing signs of overdose is also critical.
  • Disposal: Used opioid patches contain a significant amount of residual medication. Hospitals follow specific procedures, such as folding the patch with the adhesive sides together and flushing it down the toilet, to prevent accidental exposure to children or others.
  • Interaction with Heat: Patients are warned against exposing transdermal patches to direct heat, such as heating pads or saunas, as this can increase drug absorption and risk overdose.

Conclusion

Hospitals rely on a range of transdermal and topical pain patches to provide safe and effective analgesia for patients with diverse needs. Strong opioid patches, like fentanyl and buprenorphine, are reserved for severe, chronic pain, while localized solutions, like lidocaine patches, target specific nerve pain with minimal systemic effects. By offering a consistent, non-invasive method of pain relief, these patches enhance patient comfort, particularly in cases where oral medications are unsuitable. Strict safety protocols, from application to disposal, are essential in managing these potent medications within a clinical setting.

For more information on the use of transdermal buprenorphine for acute pain management in clinical settings, visit the article in Pain and Therapy available via the National Institutes of Health.

Key Takeaways

  • High-potency opioids are used for severe, chronic pain. Fentanyl and buprenorphine patches deliver consistent, long-term pain relief for conditions like cancer pain.
  • Topical lidocaine patches provide localized relief. These patches are effective for nerve pain, such as post-herpetic neuralgia, with minimal systemic side effects.
  • Transdermal delivery offers several benefits. Advantages include steady drug levels, avoidance of first-pass metabolism, and convenience for patients unable to take oral medication.
  • Specialized patches exist for acute needs. The Ionsys fentanyl patch is an example of a system specifically used in hospitals for short-term, patient-controlled pain management after surgery.
  • Strict safety protocols are essential. Due to the potency of opioid patches, proper handling and disposal are critical to prevent accidental exposure and overdose.

Frequently Asked Questions

Fentanyl is a potent opioid agonist, while buprenorphine is a partial opioid agonist. Both are used for severe chronic pain, but buprenorphine has a ceiling effect on respiratory depression, potentially making it safer in some cases.

Yes, but it depends on the type. Extended-release patches like fentanyl and buprenorphine have a slow onset and are not ideal for immediate relief. However, a patient-controlled fentanyl patch system called Ionsys is specifically used for short-term, acute post-op pain in a hospital setting.

A Lidocaine patch is primarily used to relieve localized nerve pain, such as the persistent pain associated with post-herpetic neuralgia (PHN) following a shingles infection. It works by numbing the nerves in a targeted area.

Pain patches offer a continuous, stable level of medication, which avoids the peaks and troughs of oral doses. They also bypass first-pass liver metabolism and are convenient for patients who have trouble swallowing or experience nausea.

Hospitals implement strict disposal protocols because used opioid patches still contain a significant amount of active drug. This prevents accidental exposure and potential overdose in children or others.

Yes, especially with opioid patches. External heat sources can accelerate drug absorption and lead to overdose. Poor adhesion can cause inconsistent dosing or fall off, posing a risk of accidental exposure. Patients should also be monitored for side effects like respiratory depression.

No, transdermal patches should not be cut or damaged. Doing so can cause the medication to be released too quickly, leading to a dangerous overdose. This is especially true for older reservoir-type patches and newer matrix patches.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.